Voclosporin denied as non-formulary by Aetna?

Aetna's specific coverage criteria for voclosporin are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Voclosporin as Non-Formulary

Voclosporin may sit on a restricted tier or be excluded from Aetna's standard drug formulary for a given plan year. A non-formulary denial does not mean the drug is clinically inappropriate — it means cost-management rules apply. These denials are among the most frequently overturned on appeal because the path to coverage exists in statute and in the plan's own exception procedures.

## Your Appeal Rights

• Formulary exception request: Most Aetna plans provide a formulary exception process separate from (and faster than) a formal internal appeal. Ask your prescriber to submit a formulary exception with a medical-necessity justification letter. Approval grants temporary or permanent on-formulary status.
• Internal appeal: If the exception is denied, file a formal internal appeal under ERISA §503 or applicable state law within the deadline stated on your denial notice.
• External review (ACA §2719): After exhausting internal appeal, you have roughly four months to request binding external review by an independent organization. An IRO can overturn a non-formulary exclusion when no formulary alternative is clinically appropriate.
• Expedited track: Available when standard timelines would seriously jeopardize your health.

## Key Argument: No Adequate Formulary Alternative

The strongest non-formulary appeal shows that every formulary alternative either (a) was previously tried and failed, or (b) is clinically contraindicated or inappropriate for this patient per the prescriber's judgment. You do not need to make this argument yourself — your prescriber's letter should do so, citing the patient's specific history.

## Documentation to Gather

1. Formulary alternatives tried — dates, durations, and outcomes for each Aetna-listed alternative your prescriber considered. 2. Why alternatives are inadequate — prescriber's written explanation of clinical differences between voclosporin and available alternatives (mechanism, tolerability profile, label indication) without fabricating trial statistics. 3. Active LN documentation — biopsy, labs, and clinical notes confirming the underlying diagnosis and disease activity (same package as a medical-necessity appeal). 4. Prescriber attestation — signed letter stating that voclosporin is the medically necessary agent for this patient and that no formulary substitute is clinically equivalent.

## Criteria-Mapping Structure

Review Aetna's formulary exception criteria (found in the Summary Plan Description or Evidence of Coverage). Map each criterion to your documentation:

| Exception Criterion | Your Evidence | |---|---| | Drug is medically necessary | Prescriber letter, diagnosis records | | Formulary alternative(s) tried and failed | Dated treatment history | | Formulary alternative(s) clinically inappropriate | Prescriber's clinical rationale |

Attach the FDA-approved prescribing label for voclosporin to support the specific indication and its distinct mechanism of action.